Gamma Medica

About:

Gamma Medica offers LumaGEM® MBI System, an FDA-cleared dual-headed digital imaging system.

Top Investors: Hercules Capital, Psilos Group

Description:

Gamma Medica, Inc. is proud to offer the LumaGEM® MBI System. As the first commercially available, FDA cleared, planar, dual head, fully solid state digital imaging system utilizing cadmium zinc telluride (CZT) technology used for breast imaging, LumaGEM is able to detect millimeter-size breast cancers missed by mammography, especially in women with dense breast tissue.

Total Funding Amount:

$27.5M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Salem, New Hampshire, United States

Founded Date:

2013-01-01

Contact Email:

finance(AT)gammamedica.com

Founders:

Bradley E. Patt

Number of Employees:

11-50

Last Funding Date:

2014-10-22

IPO Status:

Private

Industries: